SC H3092

Requires physicians or their staff to provide a written disclosure statement to pregnant women when administering or dispensing mifepristone (the first pill in a medication abortion)

The disclosure must inform women that mifepristone is not always effective and that they should consult a physician immediately if they regret their decision, as medication may be available to "restore progesterone and potentially strengthen the pregnancy"

Disclosure can be provided by stapling it to the misoprostol package, attaching it to the prescription, or including it with discharge instructions

Exempts cases of spontaneous miscarriage from the disclosure requirement and does not require pharmacies to provide the statement

Takes effect upon Governor's approval and includes a severability clause protecting remaining provisions if any part is found unconstitutional